Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis.

Kristian ReichCurdin ConradLars Erik KristensenSaxon D Smith Lluis L PuigPhoebe RichChristophe SapinThorsten HolzkaemperUffe KoppelhusChristopher Schuster

Published in: The Journal of dermatological treatment (2021)

In patients with moderate-to-severe psoriasis and concomitant NP, ixekizumab has the greatest likelihood among approved biologics of achieving complete resolution of NP at week 24‒26. Findings should be interpreted carefully because of inherent study limitations.

Keyphrases

systematic review
rheumatoid arthritis
single molecule
meta analyses
early onset
high intensity
clinical trial